Voya Investment Management LLC Editas Medicine, Inc. Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

A detailed history of Voya Investment Management LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 28,261 shares of EDIT stock, worth $37,021. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,261

Previous 27,950 1.11%

Holding current value

$37,021

Previous $130,000 26.15%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.39 - $5.96 $1,054 - $1,853	311 Added 1.11%	28,261 $96,000
Q2 2024 Dec 03, 2024	SELL	$4.67 - $7.28 $1,452 - $2,264	-311 Reduced 1.1%	27,950 $130,000
Q2 2024 Aug 14, 2024	BUY	$4.67 - $7.28 $2,545 - $3,967	545 Added 1.99%	27,950 $130,000
Q1 2024 Dec 06, 2024	SELL	$7.03 - $11.07 $6,017 - $9,475	-856 Reduced 3.03%	27,405 $203,000
Q1 2024 May 15, 2024	SELL	$7.03 - $11.07 $38,292 - $60,298	-5,447 Reduced 16.58%	27,405 $203,000
Q4 2023 Feb 14, 2024	SELL	$6.25 - $11.11 $4,137 - $7,354	-662 Reduced 1.98%	32,852 $332,000
Q3 2023 Nov 14, 2023	BUY	$6.92 - $9.31 $41,962 - $56,455	6,064 Added 22.09%	33,514 $261,000
Q2 2023 Aug 14, 2023	BUY	$6.36 - $11.47 $5,240 - $9,451	824 Added 3.09%	27,450 $225,000
Q1 2022 May 16, 2022	SELL	$14.08 - $27.63 $4,618 - $9,062	-328 Reduced 1.22%	26,626 $506,000
Q4 2021 Feb 14, 2022	BUY	$26.55 - $40.57 $11,867 - $18,134	447 Added 1.69%	26,954 $716,000
Q3 2021 Nov 15, 2021	SELL	$39.27 - $72.94 $24,465 - $45,441	-623 Reduced 2.3%	26,507 $1.09 Million
Q2 2021 Aug 16, 2021	SELL	$31.29 - $56.64 $67,961 - $123,022	-2,172 Reduced 7.41%	27,130 $1.54 Million
Q1 2021 May 17, 2021	BUY	$39.71 - $90.58 $82,676 - $188,587	2,082 Added 7.65%	29,302 $1.23 Million
Q4 2020 Feb 16, 2021	BUY	$27.07 - $84.35 $173,248 - $539,840	6,400 Added 30.74%	27,220 $1.91 Million
Q3 2020 Nov 16, 2020	BUY	$28.06 - $37.16 $43,885 - $58,118	1,564 Added 8.12%	20,820 $584,000
Q2 2020 Aug 14, 2020	SELL	$18.5 - $34.34 $119,880 - $222,523	-6,480 Reduced 25.18%	19,256 $570,000
Q1 2020 May 15, 2020	BUY	$14.88 - $32.78 $9,195 - $20,258	618 Added 2.46%	25,736 $510,000
Q4 2019 Feb 14, 2020	BUY	$19.49 - $32.63 $110,274 - $184,620	5,658 Added 29.08%	25,118 $744,000
Q2 2019 Aug 14, 2019	BUY	$20.48 - $27.76 $9,584 - $12,991	468 Added 2.46%	19,460 $481,000
Q4 2018 Feb 14, 2019	BUY	$18.19 - $31.79 $20,791 - $36,335	1,143 Added 6.4%	18,992 $432,000
Q2 2018 Aug 14, 2018	BUY	$31.4 - $41.01 $66,254 - $86,531	2,110 Added 13.41%	17,849 $640,000
Q1 2018 May 15, 2018	BUY	$29.84 - $44.08 $10,742 - $15,868	360 Added 2.34%	15,739 $522,000
Q3 2017 Nov 14, 2017	BUY	$15.81 - $24.01 $243,141 - $369,249	15,379	15,379 $369,000

Others Institutions Holding EDIT

# of Institutions

248

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Editas Medicine, Inc. Transaction History